Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model.


BACKGROUND MicroRNAs (miRs) are small noncoding RNAs that posttranscriptionally control gene expression. Small-animal studies suggest that miRs might offer novel therapeutic targets in cardiovascular diseases such as cardioprotection of murine hearts after myocardial infarction via miR-92a inhibitors. Because the functional benefits of miR-92a inhibitors in larger preclinical models are not known, we assessed the therapeutic efficacy of miR-92a inhibition in a porcine model of ischemia and reperfusion. METHODS AND RESULTS Pigs (n=5 per group) underwent percutaneous ischemia/reperfusion (60 min/72 h or 7 days, respectively). Locked nucleic acid-modified antisense miR-92a (LNA-92a) was applied either regionally (antegrade or retrograde) with a catheter or systemically (intravenously). LNA-92a significantly (P<0.01) reduced miR-92a expression in the infarct zone regardless of the application venue. However, catheter-based delivery, but not intravenous infusion, of LNA-92a significantly (P<0.05) reduced the infarct size compared with control LNA-treated pigs, which correlated with an improved ejection fraction and left ventricular end-diastolic pressure (P<0.05). Histochemistry revealed that LNA-92a increased capillary density but decreased leukocyte influx and cardiac cell death. Complete loss of miR-92a in mice attenuated the infarct-related myocardial dysfunction to a larger extent than cardiomyocyte-specific miR-92a deletion. In vitro, LNA-92a protected against hypoxia/reoxygenation-induced cardiomyocyte cell death. CONCLUSIONS Regional LNA-92a delivery reduces miR-92a levels and infarct size and postischemic loss of function. LNA-92a exerts cell-protective, proangiogenic, and anti-inflammatory effects. miR-92a inhibition might be a novel therapeutic tool to preserve cardiac function after ischemia.

DOI: 10.1161/CIRCULATIONAHA.113.001904

7 Figures and Tables

Citations per Year

399 Citations

Semantic Scholar estimates that this publication has 399 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Hinkel2013InhibitionOM, title={Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model.}, author={Rabea Hinkel and Daniela Penzkofer and Stefanie Z{\"{u}hlke and Ariane Fischer and Wira Husada and Quan-Fu Xu and Elisabeth Baloch and Eva van Rooij and Andreas Michael Zeiher and Christian Kupatt and Stefanie Dimmeler}, journal={Circulation}, year={2013}, volume={128 10}, pages={1066-75} }